Pharma market growth rate in Southeast Asia 2017-2030| ��ƽ��

Health, Pharma & Medtech
Pharmaceutical Products & Market

Pharma market growth rate in Southeast Asia from 2017 to 2030, by country

Characteristic	Brunei	Cambodia	Indonesia	Laos	Malaysia	Thailand	Philippines	Myanmar (Burma)	Singapore	Timor-Leste	Vietnam
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-

The chart is not accessible to screen readers. Please switch to the table view to access the data.

You need a ��ƽ�� Account for unlimited access

Immediate access to 1m+ statistics
Incl. source references
Download as PNG, PDF, XLS, PPT

Get full access

Already have an account?

Download

Source

Show detailed source information?

Already a member?

Sources

More information

Citation formats

Pharma market growth rate in Southeast Asia 2017-2030, by country

Published by ��ƽ�� Research Department, Oct 30, 2025

In 2024, Singapore ranked first by revenue change in the pharmaceuticals market among the 11 countries presented in the ranking. Singapore's revenue change amounted to **** percent, while Laos and Brunei, the second and third countries, had records amounting to **** percent and **** percent, respectively.

Further information about the methodology, more market segments, and metrics can be found on the dedicated Market ��ƽ�� page on Pharmaceuticals.